Form 4 for CRM Salesforce
Accepted 2024-04-23 00:00:00 ET · period of report 2024-04-22 · accession 0001127602-24-013269 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-04-23 | 2024-04-22 | CRM | Millham Brian | Pres, COO | M - OptEx | $76.04 | +14.2K | 8,445 | New | +$1.08M |
| DM | 2024-04-23 | 2024-04-22+ | CRM | Millham Brian | Pres, COO | S - Sale+OE | $276.59 | -10.0K | 0 | -100% | -$2.78M |
| DM | 2024-04-23 | 2024-04-22 | CRM | Millham Brian | Pres, COO | M - OptEx | $0.00 | -14.2K | 23.4K | -38% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-04-22 | M | A | 1,746 | $154.14 | 1,746 | D | — | — | |
| 2 | Common | Common Stock | 2024-04-22 | M | A | 2,037 | $186.51 | 3,783 | D | — | — | |
| 3 | Common | Common Stock | 2024-04-22 | M | A | 2,018 | $215.17 | 5,801 | D | — | — | |
| 4 | Common | Common Stock | 2024-04-23 | S | D | 3,912 | $273.15 | 4,204 | D | — | — | |
| 5 | Common | Common Stock | 2024-04-23 | S | D | 329 | $273.15 | 8,116 | D | — | — | |
| 6 | Common | Common Stock | 2024-04-22 | S | D | 5,801 | $279.10 | 0 | D | — | — | |
| 7 | Common | Common Stock | 2024-04-22 | M | A | 655 | $0.00 | 655 | D | — | — | |
| 8 | Common | Common Stock | 2024-04-22 | M | A | 7,790 | $0.00 | 8,445 | D | — | — | |
| 9 | Derivative | Non-qualified Stock Option (Right to Buy) | 2024-04-22 | M | D | 1,746 | $0.00 | 0 | D | $154.14 · 2021-04-22 to 2027-04-22 | 1,746 Common Stock | (F3) Option is exercisable and vests over four years at the rate of 25% on April 22, 2021, the first anniversary of the holder's date of grant, with the balance vesting in equal monthly installments over the remaining 36 months. |
| 10 | Derivative | Non-qualified Stock Option (Right to Buy) | 2024-04-22 | M | D | 2,018 | $0.00 | 22,196 | D | $215.17 · 2022-03-22 to 2028-03-22 | 2,018 Common Stock | (F5) Option is exercisable and vests over four years at the rate of 25% on March 22, 2022, the first anniversary of the holder's date of grant, with the balance vesting in equal monthly installments over the remaining 36 months. |
| 11 | Derivative | Non-qualified Stock Option (Right to Buy) | 2024-04-22 | M | D | 2,037 | $0.00 | 71,321 | D | $186.51 · 2024-03-22 to 2030-03-22 | 2,037 Common Stock | (F4) Option is exercisable and vests over four years at the rate of 25% on March 22, 2024, the first anniversary of the holder's date of grant, with the balance vesting in equal monthly installments over the remaining 36 months. |
| 12 | Derivative | Restricted Stock Units | 2024-04-22 | M | D | 655 | $0.00 | 0 | D | $0.00 · 2021-04-22 to 2024-04-22 | 655 Common Stock | (F6) Restricted Stock Units convert to shares of common stock on a one-for-one basis. (F7) These restricted stock units vest as to 25% of the original grant on April 22, 2021, and vest as to 1/16 of the original grant quarterly thereafter. |
| 13 | Derivative | Restricted Stock Units | 2024-04-22 | M | D | 7,790 | $0.00 | 23,371 | D | $0.00 · 2024-04-22 to 2027-04-22 | 7,790 Common Stock | (F6) Restricted Stock Units convert to shares of common stock on a one-for-one basis. (F8) These restricted stock units vest as to 25% of the original grant on April 22, 2024 and vest as to 1/16 of the original grant quarterly thereafter. |